Compare HROW & AESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | AESI |
|---|---|---|
| Founded | 1998 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2008 | 2023 |
| Metric | HROW | AESI |
|---|---|---|
| Price | $30.61 | $11.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $65.00 | $18.00 |
| AVG Volume (30 Days) | 486.5K | ★ 3.6M |
| Earning Date | 11-09-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,095,310,000.00 |
| Revenue This Year | $28.81 | $1.44 |
| Revenue Next Year | $53.97 | $16.17 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3.73 |
| 52 Week Low | $28.54 | $7.64 |
| 52 Week High | $54.98 | $20.13 |
| Indicator | HROW | AESI |
|---|---|---|
| Relative Strength Index (RSI) | 27.10 | 43.54 |
| Support Level | $28.54 | $10.78 |
| Resistance Level | $35.43 | $12.37 |
| Average True Range (ATR) | 1.25 | 0.71 |
| MACD | -0.21 | -0.16 |
| Stochastic Oscillator | 11.48 | 26.81 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Atlas Energy Solutions Inc is a provider of proppant and logistics services to the oil and natural gas industry within the Permian Basin of West Texas and New Mexico, the active oil and natural gas basin in North America. Proppant is necessary to facilitate the recovery of hydrocarbons from oil and natural gas wells. One hundred percent of its sand reserves are located in Winkler and Ward Counties, Texas, within the Permian Basin, and its operations consist of proppant production and processing facilities, including two facilities near Kermit, Texas, and a third facility near Monahans, Texas.